Holly Soares
Global Vice president & Head of Neuroscience & Rare Disease Biomarkers Roche
Seminars
Wednesday 8th October 2025
9:30 Driving Precision Medicine in Neurology Through Biomarker-Driven Development
- Exploring biomarker strategies across neurodegenerative therapeutic programs, including Alzheimer’s and rare diseases
- Insights into the application of targeted antibody therapies in advancing clinical development strategies
